Leishmania pifanoiPathogenesis: Selective Lack of a Local Cutaneous Response in the Absence of Circulating Antibody
Open Access
- 1 December 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (12) , 6597-6605
- https://doi.org/10.1128/iai.70.12.6597-6605.2002
Abstract
Recently, a role for B cells in the pathogenesis associated with infection by Leishmania (Leishmania mexicana complex and L. donovani) has been established. In the case of L. mexicana complex parasites (L. mexicana, L. pifanoi, and L. amazonensis), a critical role for immunoglobulin G-mediated mechanisms for the amastigote stage in the host is evident; however, the immunological mechanisms involved remain to be established. In vitro analysis of the kinetics of parasite uptake by macrophages failed to indicate a major effect of antibody opsonization. Given the importance of CD4+ T cells in the development of disease caused by these parasites, the possibility that the lack of pathogenesis was due to the lack of development of an immune response at the local site (draining lymph node and/or cutaneous site) was explored. Interestingly, the level of CD4+-T-cell activation (proliferation and cytokine) in draining lymph nodes from mice lacking circulating antibody (resistant) was found to be comparable to that in nodes from wild-type mice (susceptible) at 2, 5, and 10 weeks postinfection. However, antibody-deficient animals had markedly reduced numbers of monocytes and lymphocytes recruited or retained at the site of cutaneous infection in comparison to wild-type mice, indicating a selective impairment in the local cutaneous immune response. In vitro antigen presentation studies employing tissue-derived (opsonized) amastigotes demonstrated that L. pifanoi-infected FcR−/− macrophages, in contrast to comparably infected wild-type cells, failed to activate Leishmania antigen-specific T lymphocytes. These data, taken together, suggest that one possible mechanism for the role of antibody in pathogenesis may be to mediate parasite uptake and regulate the immune response at the local cutaneous site of infection.Keywords
This publication has 55 references indexed in Scilit:
- The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile CureThe Journal of Experimental Medicine, 2001
- Monocyte chemotactic protein-1 stimulates the killing of Leishmania major by human monocytes, acts synergistically with IFN-γ and is antagonized by IL-4European Journal of Immunology, 2000
- Leishmania‐infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cellsEuropean Journal of Immunology, 1996
- Disruption of CD40–CD40 Ligand Interactions Results in an Enhanced Susceptibility to Leishmania amazonensis InfectionImmunity, 1996
- Altered immune responses in mice lacking inducible nitric oxide synthaseNature, 1995
- Helper T cells without CD4: control of leishmaniasis in CD4-deficient miceScience, 1993
- Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cellsEuropean Journal of Immunology, 1993
- Transforming Growth Factor-β in Leishmanial Infection: a Parasite Escape MechanismScience, 1992
- Leishmania and the macrophage: a marriage of inconvenienceImmunology Today, 1989
- The major surface protein of leishmania promastigotes is a fibronectin‐like moleculeEuropean Journal of Immunology, 1988